Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women

Dana Meaney-Delman; Marianne E Zotti; Andreea A Creanga; Lara K Misegades; Etobssie Wako; Tracee A Treadwell; Nancy E Messonnier; Denise J Jamieson; Workgroup on Anthrax in Pregnant and Postpartum Women

doi:10.3201/eid2002.130611

Back

Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women

Journal article

Open access

Peer reviewed

Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women

Dana Meaney-Delman, Marianne E Zotti, Andreea A Creanga, Lara K Misegades, Etobssie Wako, Tracee A Treadwell, Nancy E Messonnier, Denise J Jamieson and Workgroup on Anthrax in Pregnant and Postpartum Women

Emerging infectious diseases, Vol.20(2), e130611

02/01/2014

DOI: 10.3201/eid2002.130611

PMCID: PMC3901460

PMID: 24457117

Files and links (1)

url

https://doi.org/10.3201/eid2002.130611View

Published (Version of record) Open Access

Abstract

In August 2012, the Centers for Disease Control and Prevention, in partnership with the Association of Maternal and Child Health Programs, convened a meeting of national subject matter experts to review key clinical elements of anthrax prevention and treatment for pregnant, postpartum, and lactating (P/PP/L) women. National experts in infectious disease, obstetrics, maternal fetal medicine, neonatology, pediatrics, and pharmacy attended the meeting, as did representatives from professional organizations and national, federal, state, and local agencies. The meeting addressed general principles of prevention and treatment for P/PP/L women, vaccines, antimicrobial prophylaxis and treatment, clinical considerations and critical care issues, antitoxin, delivery concerns, infection control measures, and communication. The purpose of this meeting summary is to provide updated clinical information to health care providers and public health professionals caring for P/PP/L women in the setting of a bioterrorist event involving anthrax.

Fetus

Pregnancy

United States

Adult

Anthrax - drug therapy

Anthrax - immunology

Anthrax - microbiology

Anthrax - prevention & control

Anthrax Vaccines - administration & dosage

Anti-Bacterial Agents - therapeutic use

Antibodies, Monoclonal - therapeutic use

Antitoxins - therapeutic use

Bacillus anthracis - drug effects

Bacillus anthracis - immunology

Bacillus anthracis - pathogenicity

Bioterrorism

Centers for Disease Control and Prevention (U.S.)

Female

Humans

Infant

Lactation

Postpartum Period

Practice Guidelines as Topic

Pregnancy Complications, Infectious - drug therapy

Pregnancy Complications, Infectious - immunology

Pregnancy Complications, Infectious - microbiology

Pregnancy Complications, Infectious - prevention & control

Details

Title: Subtitle: Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women
Creators: Dana Meaney-Delman
Marianne E Zotti
Andreea A Creanga
Lara K Misegades
Etobssie Wako
Tracee A Treadwell
Nancy E Messonnier
Denise J Jamieson
Workgroup on Anthrax in Pregnant and Postpartum Women
Resource Type: Journal article
Publication Details: Emerging infectious diseases, Vol.20(2), e130611
DOI: 10.3201/eid2002.130611
PMID: 24457117
PMCID: PMC3901460
NLM abbreviation: Emerg Infect Dis
ISSN: 1080-6059
eISSN: 1080-6059
Language: English
Date published: 02/01/2014
Academic Unit: Obstetrics and Gynecology; VPMA - Administration
Record Identifier: 9984446523602771

Metrics

2 Record Views